Floatz logo

NEPENTHE

Sciatica

Akdeniz UniversitySmall moleculePhase 4 / ApprovedDormant
BB
71/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
56/ 100
Competitive Position
95/ 100

Competitive context

19 Active assets in the Sciatica cohort.

Asset / SponsorPhaseRating
LIDOCAINE
C.L.A.Vleggeert-Lankamp
Phase 4BBB
DEXAMETHASONE
University of Miami
Phase 4BBB
Naproxen
Ostfold Hospital Trust
Phase 4BB
(RS)-KETOPROFEN
University Hospital, Grenoble
Phase 4BB
PREDNISONE TABLETS
Kaiser Permanente
Phase 3BB

View all 45 →

Same molecule, other indications

NEPENTHE is also rated in:

PainDormant
BBB
Indicative ·
77 / 100
View asset →
cancer of unknown primary siteDormant
BBB
Indicative ·
75 / 100
View asset →
chronic pain syndromeDormant
BBB
Indicative ·
74 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →